Key result
ADAM15 deficiency links to increased atrial fibrillation susceptibility and adverse atrial remodeling in mice.
Why the study?
ADAM15 has been implicated in AF pathogenesis, but its effect on atrial remodelling and arrhythmia susceptibility in vivo was unclear.
Does ADAM15 deficiency increase atrial fibrillation susceptibility and promote atrial remodelling in mice?
Does ADAM15 deficiency increase atrial fibrillation susceptibility and promote atrial remodelling in mice?
ADAM15 deficiency in mice increases susceptibility to atrial fibrillation by promoting arrhythmogenic atrial remodeling, including fibrosis and altered electrophysiology.
Answers are grounded in this paper and cite their sources.
Should not yet change AF management; leaves open ADAM15 as a therapeutic target pending human studies.
BACKGROUND: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with significant associated morbidity and mortality. The pathophysiology underlying AF is complex, and this has limited the development of effective therapies. ADAMs (a disintegrin and metalloproteinase) are transmembrane proteinases with diverse functions involving cell-cell communication and extracellular matrix homeostasis. ADAM15 specifically has been implicated in AF pathogenesis in large-scale genetic association studies. Given the importance of atrial remodelling in AF pathogenesis, we sought to ascertain the effect of ADAM15 deficiency in murine atrial biology. METHODS: ) mice; wildtype mice were used as controls. These studies included invasive electrophysiology, echocardiography, optical mapping and biochemical assays. RESULTS: ADAM15 deficiency resulted in increased AF susceptibility without overt abnormalities in cardiac structure or function by echocardiography. These findings were associated with shortened atrial action potential duration, increased atrial fibrosis, increased TGFβ signalling, as well as reduced connexin expression. CONCLUSIONS: Here, we provide evidence that ADAM15 deficiency is associated with increased AF susceptibility and atrial remodelling in mice. Further work will be needed to define the molecular mechanisms underlying these findings and determine their relevance to human AF.
No takes yet. Share an insight, caveat, or question.
Bapat et al. (2026) studied Atrial fibrillation. ADAM15 deficiency vs. Wildtype mice was evaluated on Atrial fibrillation susceptibility. ADAM15 deficiency in mice was associated with increased atrial fibrillation susceptibility, shortened atrial action potential duration, and increased atrial fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: